Snow Capital Management’s Biogen BIIB Stock Holding History

Snow Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$9.28M	Sell	26,786 -98	-0.4%	-$29.7K	1.32%	30
2021 Q1	$7.52M	Sell	26,884 -237	-0.9%	-$63.9K	1.09%	33
2020 Q4	$6.64M	Buy	27,121 +3,652	+16%	+$942K	1.13%	33
2020 Q3	$6.66M	Sell	23,469 -840	-3%	-$234K	1.33%	33
2020 Q2	$6.5M	Sell	24,309 -19,305	-44%	-$5.8M	1.35%	30
2020 Q1	$13.8M	Sell	43,614 -6,871	-14%	-$2.09M	3.17%	3
2019 Q4	$15M	Sell	50,485 -91,048	-64%	-$25.3M	2.08%	15
2019 Q3	$33M	Sell	141,533 -7,736	-5%	-$1.8M	2.41%	22
2019 Q2	$34.9M	Sell	149,269 -1,321	-0.9%	-$305K	2.29%	19
2019 Q1	$35.6M	Sell	150,590 -10,343	-6%	-$3.26M	2.25%	20
2018 Q4	$48.4M	Sell	160,933 -16,166	-9%	-$5.16M	3.28%	7
2018 Q3	$62.6M	Sell	177,099 -55,366	-24%	-$19.1M	3%	11
2018 Q2	$67.5M	Sell	232,465 -5,425	-2%	-$1.53M	3.1%	6
2018 Q1	$65.1M	Buy	237,890 +26,428	+12%	+$8.2M	2.99%	10
2017 Q4	$67.4M	Buy	211,462 +1,003	+0.5%	+$322K	2.99%	12
2017 Q3	$65.9M	Sell	210,459 -4,723	-2%	-$1.4M	3.18%	6
2017 Q2	$58.4M	Buy	215,182 +29,078	+16%	+$7.69M	2.9%	14
2017 Q1	$50.9M	Sell	186,104 -6,257	-3%	-$1.77M	2.38%	18
2016 Q4	$54.5M	Sell	192,361 -11,164	-5%	-$3.31M	2.46%	17
2016 Q3	$63.7M	Sell	203,525 -8,036	-4%	-$2.38M	2.86%	6
2016 Q2	$51.2M	Buy	211,561 +119,760	+130%	+$31.6M	2.41%	16
2016 Q1	$23.9M	Buy	91,801 +51,511	+128%	+$13.6M	1.05%	37
2015 Q4	$12.3M	Sell	40,290 -5,571	-12%	-$1.6M	0.49%	46
2015 Q3	$13.4M	Buy	45,861 +35,361	+337%	+$11.7M	0.48%	53
2015 Q2	$4.24M	Buy	10,500 +8,000	+320%	+$3.21M	0.12%	85
2015 Q1	$1.06M	Buy	+2,500	New	+$985K	0.03%	102

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Snow Capital Management's BIIB Position: Q2 2021 in Review

Snow Capital Management reduced its Biogen (BIIB) stake by 0.36% in Q2 2021, selling an estimated $29.7K and leaving 26,786 shares worth $9.28M. The position accounts for 1.32% of the portfolio, ranked #30.

Snow Capital Management first reported a position in BIIB in Q1 2015 and has held it in 26 quarters since. The position peaked at $67.5M in Q2 2018. 1,105 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Snow Capital Management held 26,786 shares of Biogen worth $9.28M as of Q2 2021.
Snow Capital Management sold 98 Biogen shares in Q2 2021, an estimated $29.7K.
Biogen made up 1.32% of Snow Capital Management's portfolio in Q2 2021, its #30 holding.
Snow Capital Management first reported a position in Biogen in Q1 2015 and has held it in 26 quarters since.
Snow Capital Management's Biogen position peaked at $67.5M in Q2 2018.
1,105 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.